Academic Journal
Durable recovery from amblyopia with donepezil
العنوان: | Durable recovery from amblyopia with donepezil |
---|---|
المؤلفون: | Carolyn Wu, Eric D. Gaier, Bharti R. Nihalani, Sarah Whitecross, Takao K. Hensch, David G. Hunter |
المصدر: | Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023) |
بيانات النشر: | Nature Portfolio, 2023. |
سنة النشر: | 2023 |
المجموعة: | LCC:Medicine LCC:Science |
مصطلحات موضوعية: | Medicine, Science |
الوصف: | Abstract An elevated threshold for neuroplasticity limits visual gains with treatment of residual amblyopia in older children and adults. Acetylcholinesterase inhibitors (AChEI) can enable visual neuroplasticity and promote recovery from amblyopia in adult mice. Motivated by these promising findings, we sought to determine whether donepezil, a commercially available AChEI, can enable recovery in older children and adults with residual amblyopia. In this open-label pilot efficacy study, 16 participants (mean age 16 years; range 9–37 years) with residual anisometropic and/or strabismic amblyopia were treated with daily oral donepezil for 12 weeks. Donepezil dosage was started at 2.5 or 5.0 mg based on age and increased by 2.5 mg if the amblyopic eye visual acuity did not improve by 1 line from the visit 4 weeks prior for a maximum dosage of 7.5 or 10 mg. Participants |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 2045-2322 |
Relation: | https://doaj.org/toc/2045-2322 |
DOI: | 10.1038/s41598-023-34891-5 |
URL الوصول: | https://doaj.org/article/4ff45b1787f94c3691a42fd3cedf1dc9 |
رقم الانضمام: | edsdoj.4ff45b1787f94c3691a42fd3cedf1dc9 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 20452322 |
---|---|
DOI: | 10.1038/s41598-023-34891-5 |